Moreover, the immunohistochemical identification of insulin in lung cancer tissue samples (whereby, besides the actual tumor cells, some normal pneumocytes were also revealed to be insulin-positive) in the absence of detectable insulin transcripts [32] additionally strengthens the concept of a pathological spread of (blood-borne) insulin in malignant diseases. This evidence concerns the gene INS and neoplasm.